New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
06:34 EDTAGN, VRXCapital Research sells nearly all its Allergan stake, WSJ reports
Capital Research, one of Allergan's (AGN) top shareholders, has sold most of its stake in the Botox maker after meeting with Allergan CEO David Pyott, the Wall Street Journal reports, citing sources. Allergan is looking to fend off a $53B hostile takeover offer by Valeant (VRX) and activist Bill Ackman. According to FactSet, Captial Research held a 6.3% stake in Allergan. Reference Link
News For AGN;VRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 26, 2015
17:34 EDTAGNActavis registration statement for Allergan acquisition declared effective
Subscribe for More Information
January 22, 2015
05:57 EDTVRXActavis, Valeant raise prospects of more healthcare deals, Financial Times says
Subscribe for More Information
January 21, 2015
12:30 EDTAGN, VRXGlaxoSmithKline 'admired' by Pfizer CEO, FT reports
Subscribe for More Information
07:22 EDTAGNActavis price target raised to $330 from $280 at Deutsche Bank
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use